Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapy for transthyretin-associated amyloidosis

Therapy for transthyretin-associated amyloidosis

US Patent 9610270 · Granted Apr 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triamterene or nolatrexed for use in the treatment of phenylketonuria2025
Triamterene or nolatrexed for use in the treatment of phenylketonuria2025
Sustained release compositions comprising micronized tolcapone2025
Sustained release compositions comprising micronized tolcapone2025
Sustained release compositions comprising micronized tolcapone2024
Sustained release compositions comprising micronized tolcapone2024
Therapy for transthyretin-associated amyloidosis2023
Therapy for transthyretin-associated amyloidosis2023
Therapy for transthyretin-associated amyloidosis2023
Therapy for transthyretin-associated amyloidosis2023
Therapy for transthyretin-associated amyloidosis2020
Therapy for transthyretin-associated amyloidosis2020